Novo Nordisk strikes second licensing deal since frosty capital-markets day
Published . Updated .
Novo Nordisk said Tuesday the company struck its second licensing deal since it received a poor reception from investors after presenting its long-term strategy.
Directly affected
- MSTR Strategy
Named in this report.
Indirectly affected
- LMT Lockheed Martin
Defense contractors get more work when conflict spending rises
- RTX RTX
Defense contractors get more work when conflict spending rises
- NOC Northrop Grumman
Defense contractors get more work when conflict spending rises
- GD General Dynamics
Defense contractors get more work when conflict spending rises
- ITA iShares U.S. Aerospace & Defense
A fund of aerospace and defense companies
- BA Boeing
Defense and aerospace orders move with conflict spending
- LHX L3Harris
Defense contractors get more work when conflict spending rises
- HII Huntington Ingalls
Shipyards benefit when naval spending rises
- NVO NOVO-NORDISK A S
GA selected NVO as a RELATED security because its canonical security name directly matches this event's themes: nordisk, novo. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BDGS BRIDGES CAPITAL TACTICAL ETF
GA selected BDGS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
Source: MarketWatch
The price since 29 Sep 2026: Novo Nordisk A S (NVO) versus the S&P 500
Since the first closing price after “Novo Nordisk strikes second licensing deal since frosty capital-markets day,” Novo Nordisk A S (NVO) is +1.33%. The S&P 500 fund (SPY) is +0.56% over the same days, a +0.77% difference versus the market.
Disclosure records for Novo Nordisk A S (NVO) within two months of 29 Sep 2026
- Kevin Hern sell Novo Nordisk A S (NVO) ($1,001 - $15,000). That is 19 days before publication, inside 30 days. The filing is listed beside the story “Novo Nordisk strikes second licensing deal since frosty capital-markets day.”
- Kevin Hern sell Novo Nordisk A S (NVO) ($1,001 - $15,000). That is 29 days before publication, inside 30 days. The filing is listed beside the story “Novo Nordisk strikes second licensing deal since frosty capital-markets day.”
- Scott Scott Franklin buy Novo Nordisk A S (NVO) ($1,001 - $15,000). That is 34 days before publication, inside 60 days. The filing is listed beside the story “Novo Nordisk strikes second licensing deal since frosty capital-markets day.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Novo Nordisk A S (NVO)
Companies mentioned with this story
- NVO Novo Nordisk A S
Novo Nordisk A S (NVO) is linked, with no stored direction, medium confidence in the 29 Sep 2026 story “Novo Nordisk strikes second licensing deal since frosty capital-markets day.” Reason on file: GA selected NVO as a RELATED security because its canonical security name directly matches this event's themes: nordisk, novo. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BDGS Bridges Capital Tactical Etf
In “Novo Nordisk strikes second licensing deal since frosty capital-markets day,” Bridges Capital Tactical Etf (BDGS) is linked, with no stored direction, medium confidence. Reason on file: GA selected BDGS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BNDS Series Portfolios Trust Infrastructure Capital Bond Income Etf
Series Portfolios Trust Infrastructure Capital Bond Income Etf (BNDS) is linked, with no stored direction, medium confidence in the 29 Sep 2026 story “Novo Nordisk strikes second licensing deal since frosty capital-markets day.” Reason on file: GA selected BNDS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CCFE Concourse Capital Focused Equity Etf
For “Novo Nordisk strikes second licensing deal since frosty capital-markets day,” Concourse Capital Focused Equity Etf (CCFE) is linked, with no stored direction, medium confidence. Reason on file: GA selected CCFE as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CGCB Capital Grp Fixed Incm Etf T
In “Novo Nordisk strikes second licensing deal since frosty capital-markets day,” Capital Grp Fixed Incm Etf T (CGCB) is linked, with no stored direction, medium confidence. Reason on file: GA selected CGCB as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CGCP Capital Grp Fixed Incm Etf T
Capital Grp Fixed Incm Etf T (CGCP) is linked, with no stored direction, medium confidence in the 29 Sep 2026 story “Novo Nordisk strikes second licensing deal since frosty capital-markets day.” Reason on file: GA selected CGCP as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Novo Nordisk A S (NVO)
“Novo Nordisk strikes second licensing deal since frosty capital-markets day” (29 Sep 2026) reaches Novo Nordisk A S (NVO) through this story.
Novo Nordisk A S (NVO) is on the page because GA selected NVO as a RELATED security because its canonical security name directly matches this event's themes: nordisk, novo. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, Bridges Capital Tactical Etf (BDGS), is listed for a different reason: GA selected BDGS as a RELATED security because its canonical security name directly matches this event's themes: capital. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Novo Nordisk A S (NVO), and the dates in the story
BDGS traded between 36.95 and 38.35 across 16 sessions. The latest close on file is 37.55. BNDS traded between 47.07 and 50.18 across 20 sessions. The latest close on file is 47.08. NVO traded between 36.85 and 39.89 across 20 sessions. The latest close on file is 38.41.
A simple score for Novo Nordisk A S (NVO)
46 out of 100
“Novo Nordisk strikes second licensing deal since frosty capital-markets day” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.